Olcay Aksoy is a Cardiology physician affiliated with University of California, Los Angeles. OpenAlex indexes 105 publications with 1,528 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Ucla Medical Plz Ste 630
Los Angeles, CA 900246997
Telephone
310-825-9011Provider last certified this registry record 3 Jan 2020.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year202531 payments
- Abbott LaboratoriesProgram year20253 payments
- Medtronic, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.6%Statin23.7%Atorvastatin Calcium47%Rosuvastatin Calcium38%Pravastatin Sodium16%Part D≥85 patientsBeta blocker18%Metoprolol Succinate53%Carvedilol38%Metoprolol Tartrate7%Atenolol3%Part D<11 patients+ 11 more classes in this area
Blood & clotting
9.3%Factor Xa inhibitor6.8%Eliquis87%Xarelto13%Part D<11 patientsP2Y12 inhibitor2.6%Clopidogrel100%Part D≥24 patientsMetabolism & gastrointestinal
5.8%SGLT2 inhibitor3.4%Farxiga68%Jardiance33%Part D<11 patientsPotassium supplement0.8%Potassium Chloride100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Timing of Noncardiac Surgery Following Transcatheter Aortic Valve Replacement
JACC: Cardiovascular Interventions
2024 - Racial/Ethnic Disparities in Outcomes After Percutaneous Coronary Intervention
The American Journal of Cardiology
2023 - Effects of leaflet curvature and thickness on the crimping stresses in transcatheter heart valve
Journal of Biomechanics
2023 - Trans-catheter mitral valve-in-valve replacement in a patient on venoarterial extracorporeal membrane oxygenation: a case report
European Heart Journal - Case Reports
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”